The Registry of Toxic Effects of Chemical Substances
Phosphonofluoridic acid, methyl - , isopropyl ester |
| UPDATE: February 2008 | MW: 140.11 | MF: C4H10FO2P |
SYNONYMS:
|
|
| |
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
N/R
|
N/R
|
N/R
|
N/R
|
| |||
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | cat
lethal concentration (50 percent kill): 124 mg/m3/2 minute
|
N/R
|
JAPTO* 25,393,2005
|
inhalation | cat
lethal concentration (50 percent kill): 900 mg/m3/10 minute
|
N/R
|
JAPTO* 25,393,2005
|
inhalation | dog
lethal concentration (50 percent kill): 176 mg/m3/2 minute
|
N/R
|
JAPTO* 25,393,2005
|
inhalation | dog
lethal concentration (50 percent kill): 1,220 mg/m3/10 minute
|
N/R
|
JAPTO* 25,393,2005
|
inhalation | domestic animal
lethal concentration (50 percent kill): 438 mg/m3/2 minute
|
N/R
|
JAPTO* 25,393,2005
|
inhalation | domestic animal
lethal concentration (50 percent kill): 2,270 mg/m3/10 minute
|
N/R
|
JAPTO* 25,393,2005
|
inhalation | guinea pig
lethal concentration (50 percent kill): 128 mg/m3/2 minute
|
N/R
|
85JCAE -,1126,1986
|
inhalation | guinea pig
lethal concentration (50 percent kill): 14,340 mg/m3/60 minute
|
N/R
|
TOXID9 44,161,2005
|
inhalation | guinea pig
lowest published toxic concentration: 1,434 mg/m3/60 minute
|
Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
TOXID9 44,161,2005
|
inhalation | guinea pig
lowest published toxic concentration: 143.4 mg/m3/6 minute
|
Eye: Miosis (pupilliary constriction)
|
TOXID9 44,161,2005
|
inhalation | guinea pig
lowest published toxic concentration: 7.1 µg/m3/273 minute
|
Eye: Miosis (pupilliary constriction)
|
JAPTO* 24,59,2004
|
inhalation | guinea pig
lowest published toxic concentration: 7.4 µg/m3/270 minute
|
Eye: Miosis (pupilliary constriction)
|
JAPTO* 24,59,2004
|
inhalation | guinea pig
lowest published toxic concentration: 15.5 µg/m3/67 minute
|
Eye: Miosis (pupilliary constriction)
|
JAPTO* 24,59,2004
|
inhalation | guinea pig
lowest published toxic concentration: 24.9 µg/m3/44 minute
|
Eye: Miosis (pupilliary constriction)
|
JAPTO* 24,59,2004
|
inhalation | guinea pig
lowest published toxic concentration: 52 µg/m3/38 minute
|
Eye: Miosis (pupilliary constriction)
|
JAPTO* 24,59,2004
|
inhalation | guinea pig
lowest published toxic concentration: 127 µg/m3/22 minute
|
Eye: Miosis (pupilliary constriction)
|
JAPTO* 24,59,2004
|
inhalation | guinea pig
lethal concentration (50 percent kill): 109 µg/kg
|
Behavioral: Convulsions or effect on seizure threshold | Lung, Thorax, or Respiration: Respiratory depression Lung, Thorax, or Respiration: Other changes
JAPTO* 24,501,2004
|
inhalation | guinea pig
lethal concentration (50 percent kill): 109 µg/kg
|
Biochemical: Metabolism (intermediary): Effect on inflammation or mediation of inflammation
|
JAPTO* 24,501,2004
|
inhalation | guinea pig
lethal concentration (50 percent kill): 1,450 mg/m3/10 minute
|
N/R
|
JAPTO* 25,393,2005
|
inhalation | human
lowest published toxic concentration: 87 µg/m3/10 minute
|
Eye: Miosis (pupilliary constriction) | Lung, Thorax, or Respiration: Dyspnea
TOXID9 72,160,2003
|
inhalation | human
lowest published toxic concentration: 50 µg/m3/30 minute
|
Eye: Miosis (pupilliary constriction) | Lung, Thorax, or Respiration: Dyspnea
TOXID9 72,160,2003
|
inhalation | human
lowest published toxic concentration: 35 µg/m3/1 hour
|
Eye: Miosis (pupilliary constriction) | Lung, Thorax, or Respiration: Dyspnea
TOXID9 72,160,2003
|
inhalation | human
lowest published toxic concentration: 17 µg/m3/4 hour
|
Eye: Miosis (pupilliary constriction) | Lung, Thorax, or Respiration: Dyspnea
TOXID9 72,160,2003
|
inhalation | human
lowest published toxic concentration: 13 µg/m3/8 hour
|
Eye: Miosis (pupilliary constriction) | Lung, Thorax, or Respiration: Dyspnea
TOXID9 72,160,2003
|
inhalation | human
lowest published lethal concentration: 11 mg/m3/2 minute
|
N/R
|
JAPTO* 25,393,2005
|
inhalation | human
lethal concentration (50 percent kill): 36 mg/m3/2 minute
|
N/R
|
JAPTO* 25,393,2005
|
inhalation | human
lethal concentration (95 percent kill): 24 mg/m3/2 minute
|
N/R
|
JAPTO* 25,393,2005
|
inhalation | human
lowest published lethal concentration: 90 mg/m3/10 minute
|
N/R
|
JAPTO* 25,393,2005
|
inhalation | human
lethal concentration (50 percent kill): 280 mg/m3/10 minute
|
N/R
|
JAPTO* 25,393,2005
|
inhalation | human
lethal concentration (95 percent kill): 660 mg/m3/10 minute
|
N/R
|
JAPTO* 25,393,2005
|
inhalation | human
lowest published lethal concentration: 360 mg/m3/30 minute
|
N/R
|
JAPTO* 25,393,2005
|
inhalation | human
lethal concentration (50 percent kill): 1,200 mg/m3/30 minute
|
N/R
|
JAPTO* 25,393,2005
|
inhalation | human
lethal concentration (95 percent kill): 2,730 mg/m3/30 minute
|
N/R
|
JAPTO* 25,393,2005
|
inhalation | man
lowest published toxic concentration: 90 µg/m3
|
Eye: Miosis (pupilliary constriction) | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
ARTODN 56,201,1985
|
inhalation | monkey
lowest published toxic concentration: 13.9 µg/m3/121 minute
|
Eye: Miosis (pupilliary constriction)
|
JAPTO* 24,59,2004
|
inhalation | monkey
lowest published toxic concentration: 23.7 µg/m3/87 minute
|
Eye: Miosis (pupilliary constriction)
|
JAPTO* 24,59,2004
|
inhalation | monkey
lowest published toxic concentration: 49 µg/m3/100 minute
|
Eye: Miosis (pupilliary constriction)
|
JAPTO* 24,59,2004
|
inhalation | monkey
lowest published toxic concentration: 124 µg/m3/11 minute
|
Eye: Miosis (pupilliary constriction)
|
JAPTO* 24,59,2004
|
inhalation | monkey
lowest published toxic concentration: 7.3 µg/m3/30 minute
|
Brain and Coverings: Changes in surface EEG
|
JAPTO* 24,475,2004
|
inhalation | monkey
lowest published toxic concentration: 14.6 µg/m3/5 hour
|
Blood: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
JAPTO* 24,475,2004
|
inhalation | monkey
lethal concentration (50 percent kill): 90 mg/m3/2 minute
|
N/R
|
JAPTO* 25,393,2005
|
inhalation | monkey
lethal concentration (50 percent kill): 670 mg/m3/10 minute
|
N/R
|
JAPTO* 25,393,2005
|
inhalation | mouse
lethal concentration (50 percent kill): 5 mg/m3/30 minute
|
N/R
|
DEGEA3 15,2179,1960
|
inhalation | mouse
lowest published toxic concentration: 0.5 ng/m3
|
Blood: Changes in spleen | Blood: Changes in leukocyte (WBC) count Immunological Including Allergic: Decrease in cellular immune response
TXCYAC 187,195,2003
|
inhalation | mouse
lethal concentration (50 percent kill): 21.5 mg/m3/20 minute
|
N/R
|
JAPTO* 24,459,2004
|
inhalation | mouse
lethal concentration (50 percent kill): 9 mg/m3/60 minute
|
N/R
|
JAPTO* 24,459,2004
|
inhalation | mouse
lethal concentration (50 percent kill): 5 mg/m3/180 minute
|
N/R
|
JAPTO* 24,459,2004
|
inhalation | mouse
lethal concentration (50 percent kill): 3.4 mg/m3/360 minute
|
N/R
|
JAPTO* 24,459,2004
|
inhalation | mouse
lethal concentration (50 percent kill): 3.1 mg/m3/720 minute
|
N/R
|
JAPTO* 24,459,2004
|
inhalation | mouse
lowest published toxic concentration: 3,348 mg/m3/9 minute
|
Peripheral Nerve and Sensation: Recording from peripheral motor nerve | Behavioral: Tremor Behavioral: Convulsions or effect on seizure threshold
JAPTO* 24,459,2004
|
inhalation | mouse
lowest published toxic concentration: 3,348 mg/m3/9 minute
|
Gastrointestinal: Changes in structure or function of salivary glands
|
JAPTO* 24,459,2004
|
inhalation | mouse
lowest published lethal concentration: 6,696 mg/m3/18 minute
|
Peripheral Nerve and Sensation: Flaccid paralysis without anesthesia (usually neuromuscular blockage) | Nutritional and Gross Metabolic: Weight loss or decreased weight gain
JAPTO* 24,459,2004
|
inhalation | mouse
lowest published toxic concentration: 12,360 mg/m3/30 minute
|
Peripheral Nerve and Sensation: Recording from peripheral motor nerve | Behavioral: Tremor Behavioral: Convulsions or effect on seizure threshold
JAPTO* 24,459,2004
|
inhalation | mouse
lowest published toxic concentration: 12,360 mg/m3/30 minute
|
Gastrointestinal: Changes in structure or function of salivary glands
|
JAPTO* 24,459,2004
|
inhalation | mouse
lowest published toxic concentration: 24,720 mg/m3/60 minute
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain
|
JAPTO* 24,459,2004
|
inhalation | mouse
lowest published lethal concentration: 25,900 mg/m3/50 minute
|
Peripheral Nerve and Sensation: Flaccid paralysis without anesthesia (usually neuromuscular blockage)
|
JAPTO* 24,459,2004
|
inhalation | mouse
lowest published toxic concentration: 72,500 mg/m3/100 minute
|
Peripheral Nerve and Sensation: Flaccid paralysis without anesthesia (usually neuromuscular blockage) | Behavioral: Tremor Behavioral: Convulsions or effect on seizure threshold
JAPTO* 24,459,2004
|
inhalation | mouse
lowest published toxic concentration: 72,500 mg/m3/100 minute
|
Gastrointestinal: Changes in structure or function of salivary glands
|
JAPTO* 24,459,2004
|
inhalation | mouse
lowest published lethal concentration: 101,500 mg/m3/140 minute
|
Peripheral Nerve and Sensation: Recording from peripheral motor nerve
|
JAPTO* 24,459,2004
|
inhalation | mouse
lowest published lethal concentration: 130,500 mg/m3/180 minute
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain
|
JAPTO* 24,459,2004
|
inhalation | mouse
lowest published toxic concentration: 271,320 mg/m3/280 minute
|
Peripheral Nerve and Sensation: Flaccid paralysis without anesthesia (usually neuromuscular blockage) | Behavioral: Tremor Behavioral: Convulsions or effect on seizure threshold
JAPTO* 24,459,2004
|
inhalation | mouse
lowest published toxic concentration: 271,320 mg/m3/280 minute
|
Gastrointestinal: Changes in structure or function of salivary glands
|
JAPTO* 24,459,2004
|
inhalation | mouse
lowest published lethal concentration: 310,080 mg/m3/320 minute
|
Peripheral Nerve and Sensation: Recording from peripheral motor nerve
|
JAPTO* 24,459,2004
|
inhalation | mouse
lowest published lethal concentration: 348,840 mg/m3/360 minute
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain
|
JAPTO* 24,459,2004
|
inhalation | mouse
lowest published toxic concentration: 519,080 mg/m3/380 minute
|
Peripheral Nerve and Sensation: Flaccid paralysis without anesthesia (usually neuromuscular blockage) | Behavioral: Tremor Behavioral: Convulsions or effect on seizure threshold
JAPTO* 24,459,2004
|
inhalation | mouse
lowest published toxic concentration: 519,080 mg/m3/380 minute
|
Gastrointestinal: Changes in structure or function of salivary glands
|
JAPTO* 24,459,2004
|
inhalation | mouse
lowest published toxic concentration: 983,520 mg/m3/720 minute
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain
|
JAPTO* 24,459,2004
|
inhalation | mouse
lowest published lethal concentration: 1,372,800 mg/m3/624 minute
|
Peripheral Nerve and Sensation: Recording from peripheral motor nerve
|
JAPTO* 24,459,2004
|
inhalation | mouse
lethal concentration (50 percent kill): 430 mg/m3/2 minute
|
N/R
|
JAPTO* 25,393,2005
|
inhalation | mouse
lethal concentration (50 percent kill): 3,160 mg/m3/10 minute
|
N/R
|
JAPTO* 25,393,2005
|
inhalation | mouse
lowest published toxic dose: 0.5 mg/m3/60 minute
|
Immunological Including Allergic: Uncharacterized (multiple organ involvement)
|
INHTE5 16,509,2004
|
inhalation | mouse
lowest published toxic concentration: 0.8 mg/m3/60 minute
|
Lung, Thorax, or Respiration: Other changes | Immunological Including Allergic: Decrease in cellular immune response Immunological Including Allergic: Decreased immune response
BCLPT* 94,139,2004
|
inhalation | mouse
lethal concentration (50 percent kill): 0.981 mg/m3/2 hour
|
N/R
|
TPKVAL 9,7,1967
|
inhalation | mouse
lethal concentration (50 percent kill): 0.17 ppm/2 hour
|
N/R
|
TPKVAL 9,7,1967
|
inhalation | pig
lowest published toxic concentration: 42.7 µg/m3
|
Eye: Miosis (pupilliary constriction)
|
TOXID9 72,159,2003
|
inhalation | pig
lethal concentration (50 percent kill): 6,342 mg/m3/60 minute
|
N/R
|
TOXID9 44,161,2005
|
inhalation | pig
lethal concentration (50 percent kill): 31,374 mg/m3/3 hour
|
N/R
|
TOXID9 44,161,2005
|
inhalation | pig
lethal concentration (50 percent kill): 350 mg/m3/10 minute
|
N/R
|
JAPTO* 25,393,2005
|
inhalation | pig
lowest published toxic dose: 0.43 mg/m3/60 minute
|
Eye: Miosis (pupilliary constriction)
|
INHTE5 18,143,2006
|
inhalation | pig
lowest published toxic dose: 0.214 mg/m3/10 minute
|
Eye: Miosis (pupilliary constriction)
|
INHTE5 18,143,2006
|
inhalation | pig
lowest published toxic dose: 0.22 mg/m3/180 minute
|
Eye: Miosis (pupilliary constriction)
|
INHTE5 18,143,2006
|
inhalation | rat
lowest published toxic concentration: 6.9 µg/m3/10 minute
|
Eye: Miosis (pupilliary constriction)
|
TOXID9 72,160,2003
|
inhalation | rat
lowest published toxic concentration: 4 µg/m3/30 minute
|
Eye: Miosis (pupilliary constriction)
|
TOXID9 72,160,2003
|
inhalation | rat
lowest published toxic concentration: 2.8 µg/m3/1 hour
|
Eye: Miosis (pupilliary constriction)
|
TOXID9 72,160,2003
|
inhalation | rat
lowest published toxic concentration: 1.4 µg/m3/4 hour
|
Eye: Miosis (pupilliary constriction)
|
TOXID9 72,160,2003
|
inhalation | rat
lowest published toxic concentration: 1 µg/m3/8 hour
|
Eye: Miosis (pupilliary constriction)
|
TOXID9 72,160,2003
|
inhalation | rat
lowest published lethal concentration: 380 µg/m3/10 minute
|
N/R
|
TOXID9 72,160,2003
|
inhalation | rat
lowest published lethal concentration: 190 µg/m3/30 minute
|
N/R
|
TOXID9 72,160,2003
|
inhalation | rat
lowest published lethal concentration: 130 µg/m3/1 hour
|
N/R
|
TOXID9 72,160,2003
|
inhalation | rat
lowest published lethal concentration: 70 µg/m3/4 hour
|
N/R
|
TOXID9 72,160,2003
|
inhalation | rat
lowest published lethal concentration: 51 µg/m3/8 hour
|
N/R
|
TOXID9 72,160,2003
|
inhalation | rat
lowest published toxic concentration: 0.1 mg/m3/4 hour
|
Brain and Coverings: Other degenerative changes | Liver: Other changes
TOXID9 72,163,2003
|
inhalation | rat
lowest published toxic concentration: 0.2 mg/m3/1 hour
|
Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
TXAPA9 184,67,2002
|
inhalation | rat
lowest published toxic concentration: 2.1 mg/m3
|
Behavioral: Tremor
|
TOSCF2 66,176,2002
|
inhalation | rat
lowest published lethal concentration: 2.7 mg/m3
|
Behavioral: Tremor | Behavioral: Convulsions or effect on seizure threshold Gastrointestinal: Changes in structure or function of salivary glands
TOSCF2 66,176,2002
|
inhalation | rat
lowest published toxic concentration: 0.1 mg/m3/1 hour
|
Brain and Coverings: Other degenerative changes | Eye: Miosis (pupilliary constriction)
TOXID9 44,162,2005
|
inhalation | rat
lowest published toxic concentration: 3.93 mg/m3/1 hour
|
Eye: Miosis (pupilliary constriction) | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
TOXID9 44,162,2005
|
inhalation | rat
lethal concentration (50 percent kill): 228 mg/m3/2 minute
|
N/R
|
JAPTO* 25,393,2005
|
inhalation | rat
lethal concentration (50 percent kill): 1,920 mg/m3/10 minute
|
N/R
|
JAPTO* 25,393,2005
|
inhalation | rat
lowest published toxic concentration: 3.39 mg/m3/1 hour
|
Vascular: Structural changes in vessels | Biochemical: Metabolism (intermediary): Other
TOXID9 90,15,2006
|
inhalation | rat
lowest published toxic concentration: 4 mg/m3
|
Vascular: Other changes | Biochemical: Metabolism (intermediary): Effect on inflammation or mediation of inflammation
TOXID9 90,15,2006
|
inhalation | rat
lowest published toxic dose: 18 mg/m3/10 minute
|
Gastrointestinal: Changes in structure or function of salivary glands
|
INHTE5 16,103,2004
|
inhalation | rat
lethal dose (10 percent kill): 26.7 mg/m3/10 minute
|
Behavioral: Convulsions or effect on seizure threshold | Gastrointestinal: Changes in structure or function of salivary glands
INHTE5 16,103,2004
|
inhalation | rat
lethal dose (10 percent kill): 21.6 mg/m3/10 minute
|
Behavioral: Convulsions or effect on seizure threshold
|
INHTE5 16,103,2004
|
inhalation | rat
lethal dose (20 percent kill): 22.7 mg/m3/10 minute
|
N/R
|
INHTE5 16,103,2004
|
inhalation | rat
lethal dose (70 percent kill): 23.8 mg/m3/10 minute
|
N/R
|
INHTE5 16,103,2004
|
inhalation | rat
lethal dose (40 percent kill): 28.7 mg/m3/10 minute
|
N/R
|
INHTE5 16,103,2004
|
inhalation | rat
lethal dose (80 percent kill): 35.9 mg/m3/10 minute
|
N/R
|
INHTE5 16,103,2004
|
inhalation | rat
lowest published toxic dose: 5.6 mg/m3/60 minute
|
Gastrointestinal: Changes in structure or function of salivary glands
|
INHTE5 16,103,2004
|
inhalation | rat
lethal dose (20 percent kill): 5.6 mg/m3/60 minute
|
Behavioral: Convulsions or effect on seizure threshold | Gastrointestinal: Changes in structure or function of salivary glands
INHTE5 16,103,2004
|
inhalation | rat
lethal dose (60 percent kill): 6.1 mg/m3/60 minute
|
N/R
|
INHTE5 16,103,2004
|
inhalation | rat
lowest published toxic dose: 6.1 mg/m3/60 minute
|
Behavioral: Convulsions or effect on seizure threshold
|
INHTE5 16,103,2004
|
inhalation | rat
lethal dose (40 percent kill): 7 mg/m3/60 minute
|
N/R
|
INHTE5 16,103,2004
|
inhalation | rat
lowest published toxic dose: 3.5 mg/m3/240 minute
|
Behavioral: Convulsions or effect on seizure threshold | Gastrointestinal: Changes in structure or function of salivary glands
INHTE5 16,103,2004
|
inhalation | rat
lethal dose (50 percent kill): 3.5 mg/m3/240 minute
|
Behavioral: Convulsions or effect on seizure threshold | Gastrointestinal: Changes in structure or function of salivary glands
INHTE5 16,103,2004
|
inhalation | rat
lethal dose (70 percent kill): 5.6 mg/m3/240 minute
|
N/R
|
INHTE5 16,103,2004
|
inhalation | rat
lethal dose (50 percent kill): 23.5 mg/m3/10 minute
|
N/R
|
INHTE5 16,103,2004
|
inhalation | rat
lethal dose (50 percent kill): 5.9 mg/m3/60 minute
|
N/R
|
INHTE5 16,103,2004
|
inhalation | rat
lethal dose (50 percent kill): 5.4 mg/m3/240 minute
|
N/R
|
INHTE5 16,103,2004
|
inhalation | rat
lowest published toxic dose: 1.25 mg/m3/60 minute
|
Brain and Coverings: Other degenerative changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
INHTE5 16,531,2004
|
inhalation | rat
lowest published toxic concentration: 0.4 mg/m3
|
Lung, Thorax, or Respiration: Other changes | Biochemical: Metabolism (intermediary): Effect on inflammation or mediation of inflammation
TOSCF2 97,181,2007
|
inhalation | rat
lowest published toxic concentration: 0.2 mg/m3/1 hour
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
|
TIHEEC 17,294,2001
|
inhalation | rabbit
lethal concentration (50 percent kill): 156 mg/m3/2 minute
|
N/R
|
JAPTO* 25,393,2005
|
inhalation | rabbit
lethal concentration (50 percent kill): 1,220 mg/m3/10 minute
|
N/R
|
JAPTO* 25,393,2005
|
intramuscular | dog
lethal dose (50 percent kill): 0.3 mg/kg
|
Behavioral: Convulsions or effect on seizure threshold | Lung, Thorax, or Respiration: Respiratory depression Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
JJATDK 26,439,2006
|
intramuscular | guinea pig
lowest published toxic dose: 56 µg/kg
|
Brain and Coverings: Recordings from specific areas of CNS | Behavioral: Convulsions or effect on seizure threshold
ARTODN 77,167,2003
|
intramuscular | man
lowest published lethal dose: 30 µg/kg
|
N/R
|
JCINAO 37,350,1958
|
intramuscular | monkey
lethal dose (50 percent kill): 22,300 ng/kg
|
Behavioral: Convulsions or effect on seizure threshold | Gastrointestinal: Changes in structure or function of salivary glands Skin and Appendages: Other: Hair
FAATDF 5,S169,1985
|
intramuscular | monkey
lowest published toxic dose: 2.93 µg/kg
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
|
TXCYAC 231,11,2007
|
intramuscular | mouse
lethal dose (50 percent kill): 164 µg/kg
|
N/R
|
JMCMAR 31,807,1988
|
intramuscular | rat
lethal dose (50 percent kill): 0.1 mg/kg
|
Brain and Coverings: Other degenerative changes | Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
JTEHD6 61,695,2000
|
intramuscular | rat
lowest published toxic dose: 1 µg/kg
|
Brain and Coverings: Other degenerative changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
FCTOD7 40,1327,2002
|
intramuscular | rat
lethal dose (50 percent kill): 100 µg/kg
|
N/R
|
BCPCA6 65,2041,2003
|
intramuscular | rat
lowest published toxic dose: 75 µg/kg
|
Peripheral Nerve and Sensation: Sensory syndrome diagnostic of central lesion
|
TOSCF2 66,148,2002
|
intramuscular | rat
lowest published lethal dose: 90 µg/kg
|
Peripheral Nerve and Sensation: Sensory syndrome diagnostic of central lesion | Behavioral: Convulsions or effect on seizure threshold Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other esterases
TOSCF2 66,148,2002
|
intramuscular | rat
lethal dose (50 percent kill): 100 µg/kg
|
Brain and Coverings: Other degenerative changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase Biochemical: Metabolism (intermediary): Other
TOXID9 1,84,2001
|
intramuscular | rat
lowest published lethal dose: 118 µg/kg
|
Brain and Coverings: Other degenerative changes | Behavioral: Convulsions or effect on seizure threshold Nutritional and Gross Metabolic: Weight loss or decreased weight gain
TXAPA9 209,74,2005
|
intramuscular | rat
lowest published toxic dose: 90 mg/kg
|
Brain and Coverings: Other degenerative changes
|
JPETAB 313,1082,2005
|
intramuscular | rat
lowest published toxic dose: 0.108 mg/kg
|
Brain and Coverings: Other degenerative changes | Behavioral: Convulsions or effect on seizure threshold
NRTXDN 27,277,2006
|
intraperitoneal | mouse
lethal dose (50 percent kill): 283 µg/kg
|
N/R
|
AIPTAK 172,62,1968
|
intraperitoneal | rat
lethal dose (50 percent kill): 218 µg/kg
|
N/R
|
JPETAB 139,390,1963
|
intraperitoneal | rat
lowest published toxic dose: 960 µg/kg
|
Behavioral: Change in motor activity (specific assay)
|
FCTOD7 40,1327,2002
|
intraperitoneal | rabbit
lethal dose (50 percent kill): 275 mg/kg
|
N/R
|
ENTOX* -,201,2005
|
intravenous | cat
lethal dose (50 percent kill): 22 µg/kg
|
N/R
|
JPETAB 132,50,1961
|
intravenous | dog
lethal dose (50 percent kill): 19 µg/kg
|
N/R
|
JPETAB 132,50,1961
|
intravenous | monkey
lethal dose (50 percent kill): 20 µg/kg
|
N/R
|
JTEHF8 59,387,2000
|
intravenous | mouse
lethal dose (50 percent kill): 109 µg/kg
|
Eye: Lacrimation | Lung, Thorax, or Respiration: Other changes Kidney, Ureter, and Bladder: Incontinence
JTEHD6 26,437,1989
|
intravenous | pig
lethal dose (50 percent kill): 15 µg/kg
|
N/R
|
JTEHF8 59,387,2000
|
intravenous | rat
lethal dose (50 percent kill): 39 µg/kg
|
N/R
|
JPETAB 139,390,1963
|
intravenous | rabbit
lethal dose (50 percent kill): 15 µg/kg
|
N/R
|
JMPCAS 3,353,1961
|
multiple | rat
lowest published toxic dose: 430 µg/m3/240 minute
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
|
HETOEA 24,363,2005
|
oral | human
lowest published toxic dose: 2 µg/kg
|
Behavioral: Muscle weakness | Lung, Thorax, or Respiration: Bronchiolar constriction, including asthma Gastrointestinal: Nausea or vomiting
JCINAO 37,350,1958
|
oral | man
lowest published toxic dose: 102 µg/kg/3 day- intermittent
|
Blood: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
JCINAO 37,350,1958
|
oral | rat
lethal dose (50 percent kill): 550 µg/kg
|
Behavioral: Coma | Lung, Thorax, or Respiration: Respiratory stimulation Gastrointestinal: Changes in structure or function of salivary glands
NTIS** PB158-508
|
oral | rat
lowest published toxic dose: 380 µg/kg
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
|
FCTOD7 40,1327,2002
|
subcutaneous | cat
lethal dose (50 percent kill): 30 µg/kg
|
N/R
|
TXAPA9 91,55,1987
|
subcutaneous | chicken
lethal dose (50 percent kill): 16 µg/kg
|
N/R
|
FCTOD7 40,1327,2002
|
subcutaneous | guinea pig
lethal dose (50 percent kill): 30 µg/kg
|
N/R
|
CJPPA3 46,109,1968
|
subcutaneous | guinea pig
lowest published lethal dose: 84 µg/kg
|
Brain and Coverings: Changes in surface EEG | Brain and Coverings: Other degenerative changes Behavioral: Convulsions or effect on seizure threshold
TXAPA9 188,69,2003
|
subcutaneous | guinea pig
lowest published lethal dose: 210 µg/kg
|
Brain and Coverings: Changes in surface EEG | Behavioral: Tremor Lung, Thorax, or Respiration: Respiratory depression
TXCYAC 188,197,2003
|
subcutaneous | guinea pig
lowest published toxic dose: 0.245 mg/kg
|
Behavioral: Tremor | Behavioral: Rigidity (includes catalepsy) Nutritional and Gross Metabolic: Weight loss or decreased weight gain
NRTXDN 27,485,2006
|
subcutaneous | guinea pig
lowest published lethal dose: 84 µg/kg
|
Eye: Lacrimation | Behavioral: Convulsions or effect on seizure threshold Gastrointestinal: Changes in structure or function of salivary glands
JPETAB 320,154,2007
|
subcutaneous | hamster
lethal dose (50 percent kill): 95 µg/kg
|
N/R
|
CJPPA3 46,109,1968
|
subcutaneous | mouse
lethal dose (50 percent kill): 60 µg/kg
|
N/R
|
DEGEA3 15,2179,1960
|
subcutaneous | rat
lethal dose (50 percent kill): 103 µg/kg
|
N/R
|
BJPCBM 39,822,1970
|
subcutaneous | rat
lowest published toxic dose: 120 µg/kg
|
Brain and Coverings: Changes in surface EEG | Behavioral: Convulsions or effect on seizure threshold
HBPTO* 2,1027,2001
|
subcutaneous | rat
lowest published lethal dose: 144 µg/kg
|
Behavioral: Convulsions or effect on seizure threshold | Lung, Thorax, or Respiration: Respiratory depression
TXAPA9 192,86,2003
|
subcutaneous | rat
lowest published lethal dose: 144 µg/kg
|
Brain and Coverings: Other degenerative changes | Behavioral: Convulsions or effect on seizure threshold Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
ARTODN 76,650,2002
|
subcutaneous | rat
lowest published lethal dose: 144 µg/kg
|
Behavioral: Convulsions or effect on seizure threshold
|
ARTODN 78,34,2004
|
subcutaneous | rabbit
lethal dose (50 percent kill): 30 µg/kg
|
Behavioral: Convulsions or effect on seizure threshold | Behavioral: Muscle weakness
TXAPA9 40,109,1977
|
subcutaneous | rabbit
lethal dose (50 percent kill): 30 mg/kg
|
N/R
|
ENTOX* -,201,2005
|
skin | dog
lethal dose (50 percent kill): 10.8 mg/kg
|
N/R
|
ENTOX* -,201,2005
|
skin | human
lethal dose (50 percent kill): 28 mg/kg
|
Lung, Thorax, or Respiration: Dyspnea
|
SCJUAD 3(4),33,1967
|
skin | mouse
lethal dose (50 percent kill): 1,080 µg/kg
|
Behavioral: Coma | Lung, Thorax, or Respiration: Respiratory stimulation Gastrointestinal: Changes in structure or function of salivary glands
NTIS** PB158-508
|
skin | pig
lethal dose (50 percent kill): 116 mg/kg
|
N/R
|
JTEHF8 59,387,2000
|
skin | rat
lethal dose (50 percent kill): 2,500 µg/kg
|
N/R
|
JTEHF8 59,387,2000
|
skin | rabbit
lethal dose (50 percent kill): 925 µg/kg
|
Behavioral: Coma | Lung, Thorax, or Respiration: Respiratory stimulation Gastrointestinal: Changes in structure or function of salivary glands
NTIS** PB158-508
|
skin | rabbit
lethal dose (50 percent kill): 4.4 mg/kg
|
N/R
|
ENTOX* -,201,2005
|
| |||
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | mouse
lowest published toxic concentration: 5 mg/m3/20 minute/10 day- intermittent
|
Brain and Coverings: Other degenerative changes | Spinal Cord: Other degenerative changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other esterases
JJATDK 13,143,1993
|
inhalation | mouse
lowest published toxic concentration: 5 mg/m3/10 day- intermittent
|
Behavioral: Muscle weakness | Behavioral: Ataxia Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other esterases
FCTOD7 40,1327,2002
|
inhalation | mouse
lowest published toxic concentration: 0.8 mg/m3/1 hour/3 day- intermittent
|
Lung, Thorax, or Respiration: Other changes | Immunological Including Allergic: Decrease in cellular immune response Immunological Including Allergic: Decreased immune response
BCLPT* 94,139,2004
|
inhalation | rat
lowest published toxic concentration: 0.2 mg/m3/1 hour/5 day- intermittent
|
Immunological Including Allergic: Decreased immune response
|
TOXID9 72,159,2003
|
inhalation | rat
lowest published toxic concentration: 0.2 mg/m3/5 day- intermittent
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase | Biochemical: Metabolism (intermediary): Effect on inflammation or mediation of inflammation
TXAPA9 184,67,2002
|
inhalation | rat
lowest published toxic concentration: 0.4 mg/m3/10 day- intermittent
|
Brain and Coverings: Other degenerative changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase Biochemical: Metabolism (intermediary): Effect on inflammation or mediation of inflammation
TXAPA9 184,67,2002
|
inhalation | rat
lowest published toxic concentration: 0.2 mg/m3/5 day- intermittent
|
Immunological Including Allergic: Decrease in cellular immune response
|
TXAPA9 184,82,2002
|
inhalation | rat
lowest published toxic concentration: 0.4 mg/m3/5 day- intermittent
|
Endocrine: Other changes | Immunological Including Allergic: Decrease in cellular immune response Immunological Including Allergic: Decrease in humoral immune response
TXAPA9 184,82,2002
|
inhalation | rat
lowest published toxic concentration: 0.2 mg/m3/1 hour/5 day- intermittent
|
Immunological Including Allergic: Decrease in cellular immune response | Immunological Including Allergic: Decrease in humoral immune response
TOXID9 44,5,2005
|
inhalation | rat
lowest published toxic concentration: 0.2 mg/m3/10 day- intermittent
|
Brain and Coverings: Other degenerative changes | Blood: Changes in spleen Blood: Other changes
TOXID9 60,240,2001
|
inhalation | rat
lowest published toxic concentration: 0.2 mg/m3/10 day- intermittent
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
|
TOXID9 60,240,2001
|
inhalation | rat
lowest published toxic concentration: 3.39 mg/m3/3 day- intermittent
|
Eye: Miosis (pupilliary constriction) | Behavioral: Tolerance
TOXID9 90,15,2006
|
inhalation | rat
lowest published toxic concentration: 0.4 mg/m3/1 hour/5 day- intermittent
|
Lung, Thorax, or Respiration: Other changes | Endocrine: Other changes Immunological Including Allergic: Decrease in cellular immune response
TOSCF2 97,181,2007
|
inhalation | rat
lowest published toxic concentration: 0.2 mg/m3/1 hour/5 day- intermittent
|
Brain and Coverings: Other degenerative changes | Endocrine: Other changes Immunological Including Allergic: Decrease in cellular immune response
TIHEEC 17,294,2001
|
oral | rat
lowest published toxic dose: 4,875 µg/kg/13 week- intermittent
|
Brain and Coverings: Other degenerative changes | Peripheral Nerve and Sensation: Spastic paralysis with/without sensory change Lung, Thorax, or Respiration: Dyspnea
JTEHF8 59,387,2000
|
oral | rat
lowest published toxic dose: 3,800 µg/kg/10 day- intermittent
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase Blood: Other changes
FCTOD7 40,1327,2002
|
subcutaneous | cat
lowest published toxic dose: 35 µg/kg/10 day- intermittent
|
Peripheral Nerve and Sensation: Sensory change involving peripheral nerve
|
TXAPA9 91,55,1987
|
subcutaneous | guinea pig
lowest published toxic dose: 50.4 µg/kg/2 day- intermittent
|
Behavioral: Tremor | Behavioral: Excitement
TXAPA9 215,119,2006
|
subcutaneous | guinea pig
lowest published toxic dose: 100.8 µg/kg/4 day- intermittent
|
Behavioral: Convulsions or effect on seizure threshold
|
TXAPA9 215,119,2006
|
subcutaneous | guinea pig
lowest published toxic dose: 226.8 µg/kg/11 day- intermittent
|
Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
|
TXAPA9 215,119,2006
|
subcutaneous | guinea pig
lowest published toxic dose: 105 µg/kg/5 day- intermittent
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain
|
TXAPA9 215,119,2006
|
subcutaneous | guinea pig
lowest published toxic dose: 33.6 µg/kg/2 day- intermittent
|
Blood: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
TXAPA9 215,119,2006
|
subcutaneous | guinea pig
lowest published toxic dose: 168 µg/kg/10 day- intermittent
|
Behavioral: Alteration of classical conditioning
|
TXAPA9 215,119,2006
|
subcutaneous | guinea pig
lowest published toxic dose: 168 µg/kg/12 day- intermittent
|
Brain and Coverings: Changes in surface EEG
|
TXAPA9 215,119,2006
|
subcutaneous | mouse
lowest published toxic dose: 16 µg/kg/2 day- intermittent
|
Cardiac: Other changes
|
TOXID9 44,162,2005
|
subcutaneous | mouse
: 16 µg/kg/2 day- intermittent
|
Brain and Coverings: Other degenerative changes | Cardiac: Pulse rate decreased with fall in BP Lung, Thorax, or Respiration: Other changes
EXNEAC 203,110,2007
|
subcutaneous | rat
lowest published toxic dose: 4,250 µg/kg/85 day- intermittent
|
Brain and Coverings: Other degenerative changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
APTOA6 57,234,1985
|
subcutaneous | rat
lowest published toxic dose: 1 mg/kg/40 day- intermittent
|
Behavioral: Convulsions or effect on seizure threshold | Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
RCOCB8 48,415,1985
|
subcutaneous | rat
lowest published toxic dose: 187.5 µg/kg/7 day- intermittent
|
Blood: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
JPETAB 304,1111,2003
|
subcutaneous | rat
lowest published toxic dose: 562.5 µg/kg/3 week- intermittent
|
Brain and Coverings: Recordings from specific areas of CNS | Behavioral: Change in motor activity (specific assay) Behavioral: Change in psychophysiological tests
JPETAB 304,1111,2003
|
subcutaneous | rat
lowest published toxic dose: 562.5 µg/kg/3 week- intermittent
|
Cardiac: Change in rate
|
JJATDK 26,410,2006
|
subcutaneous | rat
lowest published toxic dose: 562.5 µg/kg/3 week- intermittent
|
Brain and Coverings: Other degenerative changes | Autonomic Nervous System: Other (direct) parasympathomimetic Biochemical: Metabolism (intermediary): Other
ARTODN 80,761,2006
|
unreported route | chicken
lowest published toxic dose: 750 µg/kg/6 day- intermittent
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other esterases
|
FCTOD7 40,1327,2002
|
| |||
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
TOXICOLOGY REVIEW
|
|
RREVAH 46,1,1973
|
TOXICOLOGY REVIEW
|
|
CHREAY 48,225,1951
|
TOXICOLOGY REVIEW
|
|
TXAPA9 184,116,2002
|
TOXICOLOGY REVIEW
|
|
CPEMM* 3,239,2002
|
TOXICOLOGY REVIEW
|
|
CCATAR 366,1,2006
|
TOXICOLOGY REVIEW
|
|
TXCYAC 214,221,2005
|
TOXICOLOGY REVIEW
|
|
ENTOX* -,588,2005
|
TOXICOLOGY REVIEW
|
|
EJPHAZ 553,10,2006
|
TOXICOLOGY REVIEW
|
|
ENTOX* -,201,2005
|
TOXICOLOGY REVIEW
|
|
ENTOX* -,308,2005
|
| ||
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
N/R
|
N/R
|
N/R
|
| ||
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
N/R
|
N/R
|
N/R
|
| ||
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
EPA TSCA Section 8(b) CHEMICAL INVENTORY
|
| ||
REFERENCES:
CODEN
|
|
REFERENCE
85JCAE
|
"Prehled Prumyslove Toxikologie; Organicke Latky," Marhold, J., Prague, Czechoslovakia,
Avicenum, 1986
|
AIPTAK
|
Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of
Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898-
|
APTOA6
|
Acta Pharmacologica et Toxicologica. (Copenhagen, Denmark) V.1-59, 1945-86. For publisher
information, see PHTOEH
|
ARTODN
|
Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep.
Ger.) V.32- 1974-
|
BCLPT*
|
Basic & clinical pharmacology & toxicology (Copenhagen, Denmark : Nordic Pharmacological
Society Oxford, UK : Distributed by Blackwell Munksgaard) V.94- 2004-
|
BCPCA6
|
Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY
10523) V.1- 1958-
|
BJPCBM
|
British Journal of Pharmacology. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21
2XS, UK) V.34- 1968-
|
CCATAR
|
Clinica Chimica Acta. (Elsevier Science B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1-
1956-
|
CHREAY
|
Chemical Reviews. (American Chemical Soc., Distribution Office Dept. 223, POB 57136, West End
Stn., Washington, DC 20037) V.1- 1924-
|
CJPPA3
|
Canadian Journal of Physiology and Pharmacology. (National Research Council of Canada,
Publication Sales and Distribution, Ottawa ON K1A OR6, Canada) V.42- 1964-
|
CPEMM*
|
Clinical Pediatric Emergency Medicine (Philadelphia, PA : W.B. Saunders Co.)
|
DEGEA3
|
Deutsche Gesundheitswesen. (VEB Verlag Volk und Gesundheit, Neue Gruenstr. 18, Berlin
DDR-1020, Ger. Dem. Rep.) V.1- 1946-
|
EJPHAZ
|
European Journal of Pharmacology. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam,
Netherlands) V.1- 1967-
|
ENTOX*
|
Encyclopedia of Toxicology: Reference Book, Elsevier, 2005
|
EXNEAC
|
Experimental Neurology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-
1959-
|
FAATDF
|
Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802)
V.1-40, 1981-97. For publisher information, see TOSCF2
|
FCTOD7
|
Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford,
NY 10523) V.20- 1982-
|
HBPTO*
|
Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001
|
HETOEA
|
Human & Experimental Toxicology. (Macmillan Press Ltd., Brunel Road, Houndmills, Basingstoke,
Hampshire, RG21 2XS, UK) V.9- 1990-
|
INHTE5
|
Inhalation Toxicology. (Published by Taylor & Francis Health, 11 New Fetter Lane, London EC4P
4EE) V.1- 1989-
|
JAPTO*
|
Journal of Applied Toxicology (John Wiley & Sons, Ltd., Oldlands Way Bognor Regis West Sussex,
PO22 9SA England) V.1- 1981-
|
JCINAO
|
Journal of Clinical Investigation. (Rockefeller Univ. Press, 1230 York Ave., New York, NY
10021) V.1- 1924-
|
JJATDK
|
JAT, Journal of Applied Toxicology. (John Wiley & Sons Ltd., Baffins Lane, Chichester, W.
Sussex PO19 1UD, UK) V.1- 1981-
|
JMCMAR
|
Journal of Medicinal Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB
POB 57136, West End Stn., Washington, DC 20037) V.6- 1963-
|
JMPCAS
|
Journal of Medicinal and Pharmaceutical Chemistry. (Washington, DC) V.1-5, 1959-62. For
publisher information, see JMCMAR.
|
JPETAB
|
Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E.
Preston St., Baltimore, MD 21202) V.1- 1909/10-
|
JTEHD6
|
Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW,
Washington, DC 20005) V.1- 1975/76-
|
JTEHF8
|
Journal of Toxicology and Environmental Health, Part A. (Taylor & Francis, 47 Runway Rd.,
Suite G, Levittown, PA 19057) V.53- 1998-
|
NRTXDN
|
Neurotoxicology. (Intox Press, Inc., POB 34075, Little Rock, AR 72203) V.1- 1979-
|
NTIS**
|
National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse
for Scientific & Technical Information.
|
RCOCB8
|
Research Communications in Chemical Pathology and Pharmacology. (PJD Pub. Ltd., P.O. Box 966,
Westbury, NY 11590) V.1- 1970-
|
RREVAH
|
Residue Reviews. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ
07094) V.1- 1962-
|
SCJUAD
|
Science Journal. (London, UK) V.1-7, 1965-71. For publisher information, see NWSCAL.
|
TIHEEC
|
Toxicology and Industrial Health. (Princeton Scientific Pub. Co., POB 2155, Princeton, NJ
08540) V.1- 1985-
|
TOSCF2
|
Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 )
V. 41, Jan. 1998-
|
TOXID9
|
Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1-
1981-
|
TPKVAL
|
Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial
Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow,
USSR) No.1- 1961-
|
TXAPA9
|
Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802)
V.1- 1959-
|
TXCYAC
|
Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973-
|
| |